Literature DB >> 17409588

Impact of diabetes on cardiomyocyte apoptosis and connexin43 gap junction integrity: role of pharmacological modulation.

Jiunn-Jye Sheu1, Li-Teh Chang, Chiang-Hua Chiang, Cheuk-Kwan Sun, Nyuk-Kong Chang, Ali A Youssef, Chiung-Jen Wu, Fan-Yen Lee, Hon-Kan Yip.   

Abstract

The integrity of myocardial structures plays a crucial role in signal transductions and cardiac function. The aim of this study was to test the hypothesis that diabetes mellitus (DM) exerts adverse effects on the integrity of gap junctions (GJs) and induces cellular apoptosis in rat cardiomyocytes that can be abolished by simvastatin or losartan therapy. An experimental model of DM (induced by streptozocin 60 mg/kg body weight) in adult male rats (n = 24) was utilized to investigate the integrity of GJs containing connexin43 (Cx43) and the incidence of cellular apoptosis in the left ventricular myocardium. These rats were divided into 3 groups; group I (insulin therapy only), group II (insulin plus simvastatin 20 mg/kg/day), and group III (insulin plus losartan 20 mg/kg/day). Diabetic rats and 8 healthy rats (group IV) were sacrificed at 3 weeks following DM induction for immunofluorescence analysis. The experimental results demonstrated that the number of intact Cx43 GJs and the integrated area (mum(2)) constituted by clusters of Cx43 spots were significantly higher in groups II and IV than in group III, and in groups II-IV than in group I (all P values < 0.05). Additionally, the number of apoptotic bodies was remarkably higher in group I than in groups II-IV, and notably higher in groups II-III than in group IV (all P values < 0.05). Simvastatin is more effective than losartan at inhibiting the effects of DM on the integrity of myocardial ultrastructures. Both drugs effectively prevent cellular apoptosis in diabetic rat heart.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17409588     DOI: 10.1536/ihj.48.233

Source DB:  PubMed          Journal:  Int Heart J        ISSN: 1349-2365            Impact factor:   1.862


  6 in total

1.  Increased propensity for cell death in diabetic human heart is mediated by mitochondrial-dependent pathways.

Authors:  Ethan J Anderson; Evelio Rodriguez; Curtis A Anderson; Kathleen Thayne; W Randolph Chitwood; Alan P Kypson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-11-12       Impact factor: 4.733

Review 2.  Connexin 43 is an emerging therapeutic target in ischemia/reperfusion injury, cardioprotection and neuroprotection.

Authors:  Rainer Schulz; Philipp Maximilian Görge; Anikó Görbe; Péter Ferdinandy; Paul D Lampe; Luc Leybaert
Journal:  Pharmacol Ther       Date:  2015-06-11       Impact factor: 12.310

3.  Interaction of diet and diabetes on cardiovascular function in rats.

Authors:  Susan A Marsh; Louis J Dell'italia; John C Chatham
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-11-26       Impact factor: 4.733

4.  Extracorporeal shock wave therapy effectively prevented diabetic neuropathy.

Authors:  Yi-Ling Chen; Kuan-Hung Chen; Tsung-Cheng Yin; Tien-Hung Huang; Chun-Man Yuen; Sheng-Ying Chung; Pei-Hsun Sung; Meng-Shen Tong; Chih-Hung Chen; Hsueh-Wen Chang; Kun-Chen Lin; Sheung-Fat Ko; Hon-Kan Yip
Journal:  Am J Transl Res       Date:  2015-12-15       Impact factor: 4.060

5.  Continuing exposure to low-dose nonylphenol aggravates adenine-induced chronic renal dysfunction and role of rosuvastatin therapy.

Authors:  Chia-Hung Yen; Cheuk-Kwan Sun; Steve Leu; Christopher Glenn Wallace; Yu-Chun Lin; Li-Teh Chang; Yung-Lung Chen; Tzu-Hsien Tsa; Ying-Hsien Kao; Pei-Lin Shao; Chi-Ying Hsieh; Yen-Ta Chen; Hon-Kan Yip
Journal:  J Transl Med       Date:  2012-07-19       Impact factor: 5.531

6.  Aliskiren-attenuated myocardium apoptosis via regulation of autophagy and connexin-43 in aged spontaneously hypertensive rats.

Authors:  Wenbin Zhang; Gang Zhao; Xiaona Hu; Min Wang; Hua Li; Yong Ye; Qijun Du; Jin Yao; Zhijun Bao; Wei Hong; Guosheng Fu; Junbo Ge; Zhaohui Qiu
Journal:  J Cell Mol Med       Date:  2014-04-06       Impact factor: 5.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.